{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:50:01Z","timestamp":1791582601138,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["BBC\/F\/21\/220106"],"award-info":[{"award-number":["BBC\/F\/21\/220106"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25POST1372779"],"award-info":[{"award-number":["25POST1372779"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50HD087351"],"award-info":[{"award-number":["P50HD087351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL157281"],"award-info":[{"award-number":["R01HL157281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["1-0025"],"award-info":[{"award-number":["1-0025"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vph.2026.107709","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:20:12Z","timestamp":1791040812000},"page":"107709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CRISPR-based genome editing of smooth muscle cells: Disease models, therapeutic applications, and future perspectives"],"prefix":"10.1016","volume":"165","author":[{"given":"Qianqian","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.vph.2026.107709_bb0005","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.devcel.2022.09.015","article-title":"A single-cell transcriptomic inventory of murine smooth muscle cells","volume":"57","author":"Muhl","year":"2022","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000441-199103000-00010","article-title":"Neuromuscular disease of the gastrointestinal tract","volume":"301","author":"Chokhavatia","year":"1991","journal-title":"Am. J. Med. Sci."},{"issue":"10 Suppl","key":"10.1016\/j.vph.2026.107709_bb0015","first-page":"s191","article-title":"The epidemiology and pathophysiology of neurogenic bladder","volume":"19","author":"Ginsberg","year":"2013","journal-title":"Am. J. Manag. Care"},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1152\/japplphysiol.00950.2012","article-title":"Airway smooth muscle in the pathophysiology and treatment of asthma","volume":"114","author":"Doeing","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.vph.2026.107709_bb0025","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1016\/j.jvs.2007.03.001","article-title":"Regulation of vascular smooth muscle cell differentiation","author":"Rzucidlo","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.vph.2026.107709_bb0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbagrm.2014.06.004","article-title":"Epigenetic regulation of smooth muscle cell plasticity","volume":"1849","author":"Liu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/ATVBAHA.114.304936","article-title":"MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells","volume":"35","author":"Rodriguez","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/ATVBAHA.119.312787","article-title":"Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation","volume":"39","author":"Petsophonsakul","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvs115","article-title":"Smooth muscle cell phenotypic switching in atherosclerosis","volume":"95","author":"Gomez","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.vph.2026.107709_bb0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa2215643","article-title":"CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease","volume":"389","author":"Sharma","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2026.107709_bb0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtm.2021.05.014","article-title":"A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation","volume":"22","author":"Zhang","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"10.1016\/j.vph.2026.107709_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCRESAHA.121.319579","article-title":"Cardiac Myoediting attenuates cardiac abnormalities in human and mouse models of Duchenne muscular dystrophy","volume":"129","author":"Atmanli","year":"2021","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.vph.2026.107709_bb0070","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.122.320496","article-title":"CRISPR modeling and correction of cardiovascular disease","volume":"130","author":"Liu","year":"2022","journal-title":"Circ. Res."},{"issue":"7681","key":"10.1016\/j.vph.2026.107709_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"7603","key":"10.1016\/j.vph.2026.107709_bb0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vph.2026.107709_bb0085","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41587-021-00938-z","article-title":"Efficient C*G-to-G*C base editors developed using CRISPRi screens, target-library analysis, and machine learning","volume":"39","author":"Koblan","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","article-title":"CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells","volume":"39","author":"Kurt","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41587-020-0592-2","article-title":"Glycosylase base editors enable C-to-a and C-to-G base changes","volume":"39","author":"Zhao","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.vph.2026.107709_bb0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41587-023-01821-9","article-title":"Adenine transversion editors enable precise, efficient a*T-to-C*G base editing in mammalian cells and embryos","volume":"42","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.vph.2026.107709_bb0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","article-title":"Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase","volume":"41","author":"Tong","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0110","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1038\/s41467-024-49343-5","article-title":"Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase","volume":"15","author":"Tong","year":"2024","journal-title":"Nat. Commun."},{"issue":"7843","key":"10.1016\/j.vph.2026.107709_bb0115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"issue":"672","key":"10.1016\/j.vph.2026.107709_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade1633","article-title":"Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy","volume":"14","author":"Nishiyama","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat. Med."},{"issue":"6628","key":"10.1016\/j.vph.2026.107709_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.ade1105","article-title":"Ablation of CaMKII\u03b4 oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease","volume":"379","author":"Lebek","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat. Med."},{"issue":"43","key":"10.1016\/j.vph.2026.107709_bb0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2515267122","article-title":"Precise gene editing of pathogenic Lamin a mutations corrects cardiac disease","volume":"122","author":"Caravia","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.vph.2026.107709_bb0145","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat. Protoc."},{"issue":"7785","key":"10.1016\/j.vph.2026.107709_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vph.2026.107709_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70040","article-title":"Prime editing: the next frontier in precision gene therapy","volume":"27","author":"Aliciaslan","year":"2025","journal-title":"J. Gene Med."},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0160","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","article-title":"Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice","volume":"7","author":"Everette","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0165","article-title":"Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells","volume":"5","author":"Bulcaen","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0170","first-page":"288","article-title":"A mediator complex subunit 12 gain-of-function mutation induces partial leiomyoma cell properties in human uterine smooth muscle cells","volume":"3","author":"Takao","year":"2022","journal-title":"F S Sci"},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.116.310197","article-title":"Genome editing in cardiovascular biology","volume":"120","author":"Seeger","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1358863X251394285","article-title":"Harnessing iPSCs, 3D organoids, and multiomics to model rare vascular diseases: emerging new approach methodologies","volume":"31","author":"Liu","year":"2026","journal-title":"Vasc. Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng.3723","article-title":"An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death","volume":"49","author":"Granata","year":"2017","journal-title":"Nat. Genet."},{"issue":"14","key":"10.1016\/j.vph.2026.107709_bb0190","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.121.054744","article-title":"hiPSC modeling of lineage-specific smooth muscle cell defects caused by TGFBR1(A230T) variant, and its therapeutic implications for Loeys-Dietz syndrome","volume":"144","author":"Zhou","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2026.107709_bb0195","article-title":"Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos syndrome (vEDS) patient harboring a pathogenic c.755G>T in the COL3A1 gene","volume":"92","author":"Wu","year":"2026","journal-title":"Stem Cell Res."},{"issue":"13","key":"10.1016\/j.vph.2026.107709_bb0200","doi-asserted-by":"crossref","first-page":"E2739","DOI":"10.1073\/pnas.1620507114","article-title":"Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice","volume":"114","author":"Halim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.vph.2026.107709_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00383-013-3357-x","article-title":"Familial megacystis microcolon intestinal hypoperistalsis syndrome: a systematic review","volume":"29","author":"Mc Laughlin","year":"2013","journal-title":"Pediatr. Surg. Int."},{"issue":"11","key":"10.1016\/j.vph.2026.107709_bb0210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.126.080105","article-title":"Loss of the coronary artery disease risk gene LMOD1 in vascular smooth muscle cells triggers rapid-onset coronary atherosclerosis","volume":"154","author":"Salem","year":"2026","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bib416","doi-asserted-by":"crossref","first-page":"e14472","DOI":"10.1111\/nmo.14472","article-title":"Heterozygous Actg2(R257C) mice mimic the phenotype of megacystis microcolon intestinal hypoperistalsis syndrome","volume":"35","author":"Cai","year":"2023","journal-title":"Neurogastroenterol. Motil."},{"issue":"23","key":"10.1016\/j.vph.2026.107709_bb0215","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jgg.2023.04.013","article-title":"Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids","volume":"51","author":"Wang","year":"2024","journal-title":"J. Genet. Genomics"},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0225","doi-asserted-by":"crossref","DOI":"10.1063\/5.0244026","article-title":"Adenine base editing rescues pathogenic phenotypes in tissue engineered vascular model of Hutchinson-Gilford progeria syndrome","volume":"9","author":"Abutaleb","year":"2025","journal-title":"APL Bioeng."},{"issue":"746","key":"10.1016\/j.vph.2026.107709_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6298","article-title":"Bioengineered vascular grafts with a pathogenic TGFBR1 variant model aneurysm formation in vivo and reveal underlying collagen defects","volume":"16","author":"Yang","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.vph.2026.107709_bb0235","doi-asserted-by":"crossref","first-page":"1900386","DOI":"10.1002\/advs.201900386","article-title":"CRISPR\/Cas9 delivery mediated with hydroxyl-rich Nanosystems for gene editing in aorta","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","article-title":"Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease","volume":"84","author":"Guo","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.vph.2026.107709_bb0245","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ajmg.a.33657","article-title":"De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction","volume":"152a","author":"Milewicz","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.vph.2026.107709_bb0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40478-015-0262-7","article-title":"The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease","volume":"3","author":"Georgescu","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCGENETICS.114.000943","article-title":"Aortic disease presentation and outcome associated with ACTA2 mutations","volume":"8","author":"Regalado","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"8","key":"10.1016\/j.vph.2026.107709_bb0260","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/ajmg.a.62775","article-title":"Expanding ACTA2 genotypes with corresponding phenotypes overlapping with smooth muscle dysfunction syndrome","volume":"188","author":"Kaw","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCULATIONAHA.125.074218","article-title":"Genomic editing of a pathogenic sequence variant in ACTA2 rescues multisystemic smooth muscle dysfunction syndrome in mice","volume":"152","author":"Ding","year":"2025","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0270","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41551-025-01499-1","article-title":"Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice","volume":"10","author":"Alves","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.vph.2026.107709_bb0275","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41578-019-0145-9","article-title":"Engineered materials for in vivo delivery of genome-editing machinery","volume":"4","author":"Tong","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"7794","key":"10.1016\/j.vph.2026.107709_bb0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vph.2026.107709_bb0285","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.vph.2026.107709_bb0290","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ymthe.2025.12.067","article-title":"Deaths in gene therapy of Duchenne muscular dystrophy and other diseases: underlying mechanisms and mitigating strategies","volume":"34","author":"Duan","year":"2026","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101273","article-title":"Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies","volume":"32","author":"Chhabra","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0300","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.vph.2026.107709_bb0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+) T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.vph.2026.107709_bb0310","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ymthe.2019.11.014","article-title":"The effect of CpG sequences on capsid-specific CD8(+) T cell responses to AAV vector gene transfer","volume":"28","author":"Xiang","year":"2020","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0320","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.vph.2026.107709_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/life10120366","article-title":"Virus-like particle mediated CRISPR\/Cas9 delivery for efficient and safe genome editing","volume":"10","author":"Lyu","year":"2020","journal-title":"Life"},{"issue":"10","key":"10.1016\/j.vph.2026.107709_bb0330","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"issue":"7587","key":"10.1016\/j.vph.2026.107709_bb0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"issue":"6268","key":"10.1016\/j.vph.2026.107709_bb0340","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vph.2026.107709_bb0345","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071608","article-title":"Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing","volume":"9","author":"Naeem","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.vph.2026.107709_bb0355","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.tibtech.2019.01.009","article-title":"Improving CRISPR genome editing by engineering guide RNAs","volume":"37","author":"Moon","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"4","key":"10.1016\/j.vph.2026.107709_bb0360","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/ATVBAHA.119.312449","article-title":"Promoters to study vascular smooth muscle","volume":"39","author":"Chakraborty","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"21","key":"10.1016\/j.vph.2026.107709_bb0365","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1074\/jbc.RA118.001739","article-title":"Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts","volume":"293","author":"Gu","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.vph.2026.107709_bb0370","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s44161-022-00162-1","article-title":"Generation and comparative analysis of an Itga8-CreER (T2) mouse with preferential activity in vascular smooth muscle cells","volume":"1","author":"Warthi","year":"2022","journal-title":"Nat Cardiovasc Res"},{"issue":"15\u201316","key":"10.1016\/j.vph.2026.107709_bb0375","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/hum.2022.211","article-title":"An engineered adeno-associated virus capsid mediates efficient transduction of Pericytes and smooth muscle cells of the brain vasculature","volume":"34","author":"Ramirez","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.vph.2026.107709_bb0380","article-title":"Programmable lipid nanoparticles for RNA therapeutics: design principles and clinical translation","volume":"37","author":"Navid Talemi","year":"2026","journal-title":"Mater Today Bio"},{"issue":"22","key":"10.1016\/j.vph.2026.107709_bb0385","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.vph.2026.107709_bb0390","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.123.065117","article-title":"Elimination of CaMKII\u03b4 autophosphorylation by CRISPR-Cas9 base editing improves survival and cardiac function in heart failure in mice","volume":"148","author":"Lebek","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2026.107709_bb0395","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175164","article-title":"CRISPR-Cas9 base editing of pathogenic CaMKII\u03b4 improves cardiac function in a humanized mouse model","volume":"134","author":"Lebek","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.vph.2026.107709_bb0400","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.125.326738","article-title":"Ablation of PKCalpha phosphorylation by CRISPR-Cas9 base editing rescues heart failure","volume":"138","author":"Tadokoro","year":"2026","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.vph.2026.107709_bb0405","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.vph.2026.107709_bb0410","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.vph.2026.107709_bb0415","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:54:12Z","timestamp":1791579252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":84,"alternative-id":["S1537189126001291"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107709","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-based genome editing of smooth muscle cells: Disease models, therapeutic applications, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107709"}}